ERBB2 Gene Mutation
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation (NCT03065387) | M.D. Anderson Cancer Center | 2017-10-31 |
| Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC (NCT03066206) | M.D. Anderson Cancer Center | 2017-03-17 |
Track ERBB2 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.